Trial intelligence / Profile preview

[18F]K-40 PET imaging in healthy volunteers

jRCTs031220226Completed

Sponsor
Takeda Science Foundation
Start
Sep 2022
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Positron Emitters → Radiopharmaceuticals, Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of [18F]K-40, sponsored by Takeda Science Foundation. Primary endpoint: Primary: Volume of distribution and receptor concentration of [18F]K-40. Started Sep 2022; status: completed.

02

Drugs

[18F]K-40

Beyond the preview

Go deeper on jRCTs031220226.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCTs031220226.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call